Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06739057 · ClinicalTrials.gov registry record
Pediatric Ventricle Function Assessment Study
A clinical trial of Pulmonary Hypertension and LV Dysfunction, sponsored by HBI Solutions.
- Completed
- Registry status
- 3,993
- Enrollment target
- 1
- Study location
NCT06739057 is a study of Pulmonary Hypertension and LV Dysfunction that has completed, run by HBI Solutions. The registered enrollment target is 3,993 participants, above the 558-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (616% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06739057, a study of Pulmonary Hypertension and LV Dysfunction, has completed, sponsored by HBI Solutions.
- COMPLETED
- Registry status
- 3,993 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop a deep learning-based framework for right ventricular (RV) segmentation, prediction of RV fractional area change (FAC), and identification of pediatric RV dysfunction. The AI model was designed to distinguish between normal pediatric hearts, pulmonary hypertension (PH), and Tetralogy of Fallot (TOF). To improve diagnostic accuracy, the investigators extended the analysis beyond the A4C view by integrating data from both A4C and PSAX views. Additionally, the framework was applied to predict left ventricular ejection fraction (LV EF), further showcasing its versatility and clinical utility.
Conditions Studied
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,993 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06739057
The ClinicalTrials.gov registry entry for NCT06739057 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,993 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 558-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (616% higher). The listed sponsor is HBI Solutions, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT06739057 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06739057 about?
NCT06739057 is a clinical study titled "Pediatric Ventricle Function Assessment Study". This study aims to develop a deep learning-based framework for right ventricular (RV) segmentation, prediction of RV fractional area change (FAC), and identification of pediatric RV dysfunction. The AI model was designed to distinguish between normal pediatric hearts, pulmonary hypertension (PH), an...
What is the current status of trial NCT06739057?
This trial is currently completed. The enrollment target is 3,993 participants. The study started on 2014-01-01. Estimated completion is 2024-08-31.
What conditions does trial NCT06739057 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, LV Dysfunction, RV - Right Ventricular Abnormality, TOF.
Who is sponsoring clinical trial NCT06739057?
This trial is sponsored by HBI Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06739057 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.